Analysis of eicosanoid mediation of the renal functional effects of hyperchloremia

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 1, 1997, Pages 101-107

  Askari, Bardia ^a   Bell Quilley, Caroline P ^a,b   Fulton, David ^a   Quilley, John ^a   McGiff, John C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CHLORIDE; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; IFETROBAN; INDOMETACIN; OZAGREL; PIRMAGREL; PROSTAGLANDIN ENDOPEROXIDE; PROSTAGLANDIN H2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURESIS; ELECTROLYTE EXCRETION; GLOMERULUS FILTRATION RATE; HYPERCHLOREMIA; KIDNEY FUNCTION; KIDNEY PERFUSION; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; VASOCONSTRICTION;

ANIMALS; BODY WATER; CHLORIDES; EICOSANOIDS; ELECTROLYTES; GLOMERULAR FILTRATION RATE; HYDROXYEICOSATETRAENOIC ACIDS; KIDNEY; MALE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2;

EID: 0030850395     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ABE, T., TAKEUCHI, K., TAKAHASHI, N., TSUTSUMI, E., TANIYAMA, Y. AND ABE, K.: Rat kidney thromboxane receptor: Molecular cloning, signal transduction, and intrarenal expression localization. J. Clin. Invest. 96: 657-664, 1995.
2. 2 receptor in the rat kidney. Kidney Int. 49: 1207-1213, 1996.
3. BULLIVANT, E. M. A., WILCOX, C. S., WELCH, W. J.: Intrarenal vasoconstriction during hypochloremia: Role of thromboxane. Am. J. Physiol. 256: F152-F157, 1989.
4. ESCALANTE, B., ERLIJ, E., FALCK, J. R., MCGIFF, J. C.: Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science. 251: 799-802, 1991.
5. ESCALANTE, B., SESSA, W. C., FALCK, J. R., YADAGIRI, P., LANIADO SCHWARTZMAN, M.: Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. J. Pharmacol. Exp. Ther. 248(1): 229-232, 1989.
6. 2 receptors: Comparison to rat platelets. Eur. J. Pharm. 227: 71-78, 1992.
7. 2 receptors: Distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J. Pharmacol. Exp. Ther. 258(1): 74-81, 1991.
8. 2 receptors. Fed. Proc. 46: 149-153, 1987.
9. HARDER, D. R., NARAYANAN, J., GEBREMEDHIN, D., ROMAN, R. J.: Transduction of physical force by the vascular wall: Role of phospholipase C and cytochrome P450 metabolites of arachidonic acid. Trends Cardiovasc. Med. 5: 7-14, 1995.
10. 2 release. Hypertension 25: 1238-1244, 1995.
11. HILL, E., FITZPATRICK, F., MURPHY, R. C.: Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet. Br. J. Pharmacol. 106: 267-274, 1992.
12. 2 receptor isoforms in human platelets. J. Clin. Invest. 97: 949-956, 1996.
13. LANIADO-SCHWARTZMAN, M., FALCK, J. R., YADAGIRI, P. AND ESCALANTE, B.: Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase: Formation and identification of novel endothelium-dependent vasoconstrictor metabolite. J. Biol. Chem. 264: 11658-11662, 1989.
14. MCGIFF, J. C.: Cytochrome P450 metabolism of arachidonic acid. Ann. Rev. Pharmacol. Toxicol. 31: 339-369, 1991.
15. MEAGHER, E. A., FITZGERALD, G. A.: Disordered eicosanoid formation in pregnancy-induced hypertension. Circulation 88: 1324-1333, 1993.
16. MISTRY, M., NASJLETTI, A.: Prostanoids as mediators of prohypertensive and antihypertensive mechanisms. Am. J. Med. Sci. 31: 263-267, 1988.
17. OGLETREE, M. L., HARRIS, D. N., GREENBERG, R., HASLANGER, M. F., NAKANE, M.: Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J. Pharmacol. Exp. Ther. 234: 435-441, 1985.
18. 2/prostaglandin endoperoxide receptor antagonist. J. Pharmacol. Exp. Ther. 264: 570-578, 1993.
19. QUILLEY, C. P., LIN, Y-S. R., MCGIFF, J. C.: Chloride anion concentration as a determinant of renal vascular responsiveness to vasoconstrictor agents. Br. J. Pharmacol. 108: 106-110, 1993.
20. QUILLEY, C. P., MCGIFF, J. C.: Isomers of 12-hydroxy-5,8,10,14 eicosatetraenoic acid reduce renin activity and increase water and electrolyte excretion. J. Pharmacol. Exp. Ther. 254: 774-780, 1990.
21. QUILLEY, J., MCGIFF, J. C.: Renal vascular responsiveness to arachidonic acid in experimental diabetes. Br. J. Pharmacol. 100: 336-340, 1990.
22. 2 receptor. J. Biol. Chem. 268: 19256-19261, 1994.
23. ROSNER, B.: Fundamentals of Biostatistics. PWS-Kent, Boston, MA, 1990.
24. SCHNERMANN, J., PLOTH, D. W., HERMLE, M.: Activation of tubulo-glomerular feedback by chloride transport. Pflugers Arch. 362: 229-240, 1976.
25. SCHWARTZMAN, M. L., ABRAHAM, N. G., CARROLL, M. A., LEVERE, R. D. AND MCGIFF, J. C.: Regulation of arachidonic acid metabolism by cytochrome P-450 in rabbit kidney. Biochem. J. 238: 283-290, 1986.
26. 2 receptors. J. Clin. Invest. 90: 136-141, 1992.
27. WILCOX, C. S., RODDIS, S., PEART, W. S., GORDON, D., LEWIS, G. P.: Intrarenal prostaglandin release: Effects of arachidonic acid and hypochloremia. Kidney Int. 28: 43-50, 1985.
28. YIN, K, MCGIFF, J. C., BELL-QUILLEY, C. P.: Role of chloride in the variable response of the kidney to cyclooxygenase inhibition. Am. J. Physiol. 268: F561-F568, 1995.
29. Zou, A-P., IMIG, J. D., KALDUNSKI, M., ORTIZ DE MONTELLANO, P. R., SUI, Z., ROMAN, R. J.: Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am. J. Physiol. 266: F275-F282, 1994.